001PDF icon Efficacy of Mogamulizumab in Combination Therapy for Relapsed or Refractory Sézary Syndrome | Jordan Pilkington, BA
002Evaluation of Long-term Responses of Use of Chlormethine in Mycosis Fungoides | Silvia Alberti-Violetti, MD, PhD
003A Case Report on the Utilization of Excimer 308 nm Lamp Therapy in Treatment of Early-stage Mycosis Fungoides | Christina Asare, BS
004Mogamulizumab-induced Cardiotoxicity in Cutaneous T-Cell Lymphoma | Megan Trager, MD, MS
005PDF icon Surgical Treatment for Cutaneous B-cell Lymphoma | Thais Buffo, MD
006Moga-stop Study: Outcome  of Patients with Sézary Syndrome Treated with Mogamulizumab, after Treatment Discontinuation (Progression Excluded) | Martine Bagot, MD, PhD
007Evolution of the First Cohort of Patients with Mycosis Fungoides and Sézary Syndrome Undergoing Allogeneic Hematopoietic Progenitor Cell Transplantation in Argentina | Paula Enz, MD
008Radiation Therapy Combined with Hematopoietic Stem Cell Transplantation for T-Cell Lymphomas | Savita Dandapani, MD, PhD
009Chlormethine Gel as Active and as Maintenance Treatment in Mycosis Fungoides Patients Stages IA IIB | Marios Koumourtzis, MD, MSc
010Trial in Progress: EORTC 1820 MOGAT – Mogamulizumab Plus Total Skin Electron Beam Therapy in Stage IB-IIB Cutaneous T-Cell Lymphoma | Pablo L. Ortiz-Romero, MD, PhD
011Intralesional Rituximab Therapy for the Treatment of Primary Cutaneous B-Cell Lymphoma: A Small Case Series | Jori Hardin, MD
012Concurrent Papular and Dyshidrotic Mycosis Fungoides in a Black Patient | Jori Hardin, MD
013Omental-predominant Subcutaneous Panniculitis-like T-Cell Lymphoma Simulating Peritoneal Carcinomatosis | Ben J. Friedman, MD
014The Development of Two Clonally and Histologically Distinct Subtypes of Extranodal B-Cell Lymphomas in the Brain and Skin in One Individual | Jenna Mandel, BS
015Widespread Visceral Metastasis in a Large Cell Transformed Mycosis Fungoides Patient in a Clinical Complete Cutaneous Response | Jennifer A. DeSimone, MD
016Lymphomatoid Papulosis with an Unusually Prominent B-Cell Population and Features of T Follicular Helper Phenotype | John S. Runge, MD, PhD
017Systemic Anaplastic Large Cell Lymphoma with Unbalanced DUSP22 Gene Rearrangement Exclusively Involving the Skin | John S. Runge, MD, PhD
018Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective: Case Report | Paula Enz, MD
019Epstein-Barr Virus Positive Mucocutaneous Ulcer and Atypical Mycobacteria Infection in an Immunosuppressed Patient Associated with Methotrexate | Paula Enz, MD
020Unexplained Persistent Transaminitis in a Patient with Sézary Syndrome | Caitlyn Myrdal, MD
021Mycosis Fungoides Presenting as Dermatomyositis: A Diagnostic Challenge | Jacqueline M. Junkins-Hopkins, MD
022From Atopy to Sézary Syndrome and Back Again: A Case Report of Sézary Syndrome Diagnosis Secondary to Dupilumab Use with Spontaneous Improvement after Dupilumab Cessation | Martha Lodyga, MD
023Mycosis Fungoides - A Story of Non-pruritic Rash Unveiling T-Cell Non-Hodgkin's Lymphoma | Neil Vuppala, BA
024The Spectrum of CD8+ Cutaneous T-Cell Lymphomas: Clinical, Histologic, and Phenotypic Variants | Madisen Swallow, MS
025Poikilodermatous Mycosis Fungoides in an 18-year-old Filipino Female | Cybill Dianne C. Uy, MD
026New Frontier: A Complex Case of a 65-year-old Filipino Male with Sézary Syndrome  | Precious U. Imam, MD, DPDS
027Diffuse Large B-Cell Lymphoma of the Skin with Colonization of a Haemangioma Mimicking Intravascular Large B-Cell Lymphoma Benjamin Ho, MBBS, MRCP
028Tumor Stage Mycosis Fungoides in a 5-year-old | Rishabh Lohray, BS
029PDF icon Mycosis Fungoides in Pregnancy: Disease Activity and Outcomes | Rishabh Lohray, BS (Classification/Epidemiology/Prognostic Factors)
030Primary Cutaneous Epidermotropic, Cytotoxic, ALK+ T-Cell Lymphoma: Appraisal of a Discrete Pattern of Disease Italo Francesco Aromolo, MD
031GATA3 Expression in CD4 Small/Medium-sized Pleomorphic Lymphoproliferative Disorder: Evaluation of T Follicular Helper Subsets Italo Francesco Aromolo, MD
032Is Small-plaque Parapsoriasis the Right Term? Clinico-pathological Evaluation of 30 Cases | Italo Francesco Aromolo, MD
033Cutaneous T-Cell Lymphoma and Dupilumab Use: A Retrospective Matched Cohort Study of Clinical Characteristics and Treatment Outcomes | Robert Stuver, MD
034Updates on CTCL Diagnostic and Therapeutic Trends Amidst the COVID-19 Pandemic: Insights from an Italian Referral Center | Gabriele Roccuzzo, MD
035Preliminary Insights on Different Erythroderma Morphological Features: A Prospective Validation Study | Gabriele Roccuzzo, MD
036Changes to Mycosis Fungoides and Sézary Syndrome Clinical Trials after the 2011 Tri-societies Guidelines | Simon J. Gunter, MPhil
037Cutaneous Lymphoproliferative Disorders after COVID-19 Vaccination: Analysis of 50 International Cases Emily R. Gordon, BA
038Passing Notes: Designing a Standardized CTCL Note Template Based on ISCL Expert Consensus | Emily R. Gordon, BA
039From Pause to Progression: Lessons for CTCL Maintenance Therapy from the COVID-19 Pandemic | Emily R. Gordon, BA
040Visceral Involvement in Cutaneous T-Cell Lymphoma: Clinical Characteristics  and Outcomes | Sima Rozati, MD, PhD
041Mogamulizumab-associated Myasthenia Gravis: A Patient Report | Sima Rozati, MD, PhD (Challenging Cases of Cutaneous Lymphomas)
042PDF icon Presentation and Outcomes of Cutaneous T-Cell Lymphoma Following the Use of Dupilumab Compared to Other Biologic Therapies | Sima Rozati, MD, PhD (Biologic Insights)
043Outcomes with Sequencing of Romidepsin Followed by Mogamulizumab for the Treatment of Cutaneous T-Cell Lymphomas Emily R. Gordon, BA (Biologic Insights)
044Cutaneous T-Cell Lymphoma Clinical Trial Enrollment and Reporting Demographics: A Systematic Review | Leore Lavin, MS
045US FDA Reports of Cutaneous T-Cell Lymphoma and Lymphoma-related Events Associated with Dupilumab | Leore Lavin, MS
046Clinicoprognostic Implications of Blood Eosinophilia and Tissue Eosinophil Infiltration in Mycosis Fungoides: A Retrospective Cohort Study | Woo Jin Lee, MD, PhD
047PDF icon Mycosis Fungoides and Associated Malignancies in a Dutch Nationwide Retrospective Cohort Study | Rosanne Ottevanger, MD
048Risk of Systemic Lymphoma in Patients with Cutaneous CD30+ Lymphoproliferative Disorder: A Single Center Retrospective Analysis Michi Shinohara, MD
049Histopathological Features of Mycosis Fungoides in a Cohort of Asian Children | Mark Jean-Aan Koh, MBBS
050Chemical Exposures and Demographic Associations in Cutaneous T-Cell Lymphoma: A Large Single Institution Physician Validated Cohort Study | Yanzhen (Janet) Pang, BS
051Clinicopathological Features and Mortality in Patients Folliculotropic Mycosis Fungoides: A Retrospective Analysis | Kelly Meza, MD
052Granulomatous Mycosis Fungoides: A Retrospective Cohort Study | Samruddhi Arkatkar, BS
053Mogamulizumab for the Treatment of Cutaneous T-Cell Lymphoma: Characterization of Patients Achieving Skin Response Rachel E. Christensen, MD
054Overall and Cause-specific Mortality Among Patients with Cutaneous T-Cell Lymphoma from the United States | Lauren Shea, MD
055Prognostic Factors Based on the Tumor Microenvironment In Primary Cutaneous B-Cell Lymphoma: Retrospective Study of 216 Biopsies | Gabor Dobos, MD, PhD
056The Diagnostic Value of CD4+CD7-CD26- (Double-negative) T Cells from Flow Cytometry in the Diagnosis and Follow up of Mycosis Fungoides and Sézary Syndrome: A Prospective Study | Gabor Dobos, MD, PhD
057New Marker for the Diagnosis of Mycosis Fungoides | Ekaterina Dunaeva, MD
058The Use of Flow Cytometry of Skin Lesions as a Complementary Diagnostic Method for Cutaneous T-Cell Lymphoma Rodrigo Cesar Davanco
059A Study of DR-01 in Subjects with Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas | Kimberley Dilley, MD, MPH
060Phase 1 Pharmacodynamic and Pharmacokinetic Study of the Geranylgeranyltransferase I Inhibitor PTX-100 in Patients with Advanced Malignancies with an Expansion Cohort Recruiting T-Cell Lymphoma Patients | H. Miles Prince AM, MBBS (Hons), MD
061PDF icon Lymphatic Delivery of Pembrolizumab to Tumor Draining  Lymph Nodes in Relapsed or Refractory Mycosis Fungoides Russell Ross, PhD
062A Phase 1a/1b Trial of ST-001, a Fenretinide (4-HPR) Phospholipid Suspension for 4-hour Intravenous Infusion, in Relapsed/Refractory T-Cell Non-Hodgkin’s Lymphoma (NCT04234048) | Oleg E. Akilov, MD, PhD
063The Role of PET/CT in the Staging of Mycosis Fungoides and Sézary Syndrome | Jade Cury-Martins, MD, PhD
064PDF icon Subcutaneous Panniculitis-like T-Cell Lymphoma: A Diagnostic Challenge | Juliana Yumi Massuda Serrano, MD, MSc (Challenging Cases of Cutaneous Lymphomas)
065PDF icon If Purpuric Lesions, Think of Mycosis Fungoides | Juliana Yumi Massuda Serrano, MD, MSc (Challenging Cases of Cutaneous Lymphomas)
066PDF icon Exuberant Primary Cutaneous Marginal Zone B-Cell Lymphoma with Orbital Invasion Juliana Yumi Massuda Serrano, MD, MSc (Challenging Cases of Cutaneous Lymphomas)
067PDF icon Ichthyosiform Lesions: Think “Lymphomatously” | Juliana Yumi Massuda Serrano, MD, MSc (Challenging Cases of Cutaneous Lymphomas)
068PDF icon Assessment of Infection Profile and Incidence of Other Malignant Neoplasms in Patients with Mycosis Fungoides and Sézary Syndrome | Juliana Yumi Massuda Serrano, MD, MSc (Quality of Life/Patient-Reported Outcomes)
069PDF icon Unexpected Evolution with Psoriasis and Atopic Dermatitis Treatments: The Need to Consider a Lymphoma Juliana Yumi Massuda Serrano, MD, MSc (Quality of Life/Patient-Reported Outcomes)
070PDF icon Unusual Connection: Are There Links Between Pachydermatous Eosinophilic Dermatitis and Granulomatous Slack Skin? | Elisa Nunes Secamilli, MD (Challenging Cases of Cutaneous Lymphomas)
071PDF icon Nodular Skin Infiltrations – Pseudolymphoma vs. Lymphomatous Infiltration? | Elisa Nunes Secamilli, MD (Challenging Cases of Cutaneous Lymphomas)
072PDF icon Treatment of Bartonella Henselae Infection as a Modifying Factor of the Immune Response in Sézary Syndrome Elisa Nunes Secamilli, MD (Challenging Cases of Cutaneous Lymphomas)
073PDF icon Clinical and Histological Differences Between Pediatric Pityriasis Lichenoides and Hypopigmented Mycosis Fungoides| Elisa Nunes Secamilli, MD (Challenging Cases of Cutaneous Lymphomas)
074PDF icon Incidence of Bartonella Sp. Bacteremia on Patients with Cutaneous T-Cell Lymphomas and Healthy Subjects: A Pilot Study | Elisa Nunes Secamilli, MD (Pathogenesis/Biomarkers)